FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4384197655> ?p ?o ?g. }

• W4384197655 abstract "For locally advanced cervical cancer (LACC), patients who respond to chemotherapy have a potential survival advantage compared to nonresponsive patients. Thus, it is necessary to explore specific biological markers for the efficacy of chemotherapy, which is beneficial to personalized treatment.In the present study, we performed a comprehensive screening of site-specific N-glycopeptides in serum glycoproteins to identify glycopeptide markers for predicting the efficacy of chemotherapy, which is beneficial to personalized treatment. In total, 20 serum samples before and after neoadjuvant chemotherapy (NACT) from 10 LACC patients (NACT response, n=6) and NACT nonresponse, n=4) cases) were analyzed using LC-MS/MS, and 20 sets of mass spectrometry (MS) data were collected using liquid chromatography coupled with high-energy collisional dissociation tandem MS (LC-HCD-MS/MS) for quantitative analysis on the novel software platform, Byos. We also identified differential glycopeptides before and after chemotherapy in chemo-sensitive and chemo-resistant patients.In the present study, a total of 148 glycoproteins, 496 glycosylation sites and 2279 complete glycopeptides were identified in serum samples of LACC patients. Before and after chemotherapy, there were 13 differentially expressed glycoproteins, 654 differentially expressed glycopeptides and 93 differentially expressed glycosites in the NACT responsive group, whereas there were 18 differentially expressed glycoproteins, 569 differentially expressed glycopeptides and 99 differentially expressed glycosites in the NACT nonresponsive group. After quantitative analysis, 6 of 570 glycopeptides were identified as biomarkers for predicting the sensitivity of neoadjuvant chemotherapy in LACC. The corresponding glycopeptides included MASP1, LUM, ATRN, CO8A, CO8B and CO6. The relative abundances of the six glycopeptides, including MASP1, LUM, ATRN, CO8A, CO8B and CO6, were significantly higher in the NACT-responsive group and were significantly decreased after chemotherapy. High levels of these six glycopeptides may indicate that chemotherapy is effective. Thus, these glycopeptides are expected to serve as biomarkers for predicting the efficacy of neoadjuvant chemotherapy in locally advanced cervical cancer.The present study revealed that the N-glycopeptide of MASP1, LUM, ATRN, CO8A, CO8B and CO6 may be potential biomarkers for predicting the efficacy of chemotherapy for cervical cancer." @default.
• W4384197655 created "2023-07-14" @default.
• W4384197655 creator A5006047758 @default.
• W4384197655 creator A5008480409 @default.
• W4384197655 creator A5018713975 @default.
• W4384197655 creator A5045307915 @default.
• W4384197655 creator A5050374563 @default.
• W4384197655 creator A5072580346 @default.
• W4384197655 creator A5076983796 @default.
• W4384197655 date "2023-07-13" @default.
• W4384197655 modified "2023-10-09" @default.
• W4384197655 title "Intact glycopeptides identified by LC-MS/MS as biomarkers for response to chemotherapy of locally advanced cervical cancer" @default.
• W4384197655 cites W1182461782 @default.
• W4384197655 cites W1975372481 @default.
• W4384197655 cites W1975694462 @default.
• W4384197655 cites W1977706128 @default.
• W4384197655 cites W1983303180 @default.
• W4384197655 cites W2001855472 @default.
• W4384197655 cites W2019607817 @default.
• W4384197655 cites W2024191848 @default.
• W4384197655 cites W2045598378 @default.
• W4384197655 cites W2127579767 @default.
• W4384197655 cites W2143863671 @default.
• W4384197655 cites W2170091237 @default.
• W4384197655 cites W2175646320 @default.
• W4384197655 cites W2319132610 @default.
• W4384197655 cites W2418536297 @default.
• W4384197655 cites W2480089904 @default.
• W4384197655 cites W2483772557 @default.
• W4384197655 cites W2512344700 @default.
• W4384197655 cites W2560757057 @default.
• W4384197655 cites W2800129620 @default.
• W4384197655 cites W2806299764 @default.
• W4384197655 cites W2889646458 @default.
• W4384197655 cites W2899512749 @default.
• W4384197655 cites W2901537961 @default.
• W4384197655 cites W2921437380 @default.
• W4384197655 cites W2922345574 @default.
• W4384197655 cites W2946579137 @default.
• W4384197655 cites W3010011006 @default.
• W4384197655 cites W3043072521 @default.
• W4384197655 cites W3092934995 @default.
• W4384197655 cites W3094546658 @default.
• W4384197655 cites W3094825391 @default.
• W4384197655 cites W3104968584 @default.
• W4384197655 cites W3154239981 @default.
• W4384197655 cites W3159350553 @default.
• W4384197655 cites W3194281465 @default.
• W4384197655 cites W4206029776 @default.
• W4384197655 cites W4283262389 @default.
• W4384197655 cites W4285082442 @default.
• W4384197655 cites W4304687858 @default.
• W4384197655 cites W4321601059 @default.
• W4384197655 cites W4323665200 @default.
• W4384197655 cites W4362673120 @default.
• W4384197655 cites W4377565628 @default.
• W4384197655 doi "https://doi.org/10.3389/fonc.2023.1149599" @default.
• W4384197655 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37519786" @default.
• W4384197655 hasPublicationYear "2023" @default.
• W4384197655 type Work @default.
• W4384197655 citedByCount "1" @default.
• W4384197655 crossrefType "journal-article" @default.
• W4384197655 hasAuthorship W4384197655A5006047758 @default.
• W4384197655 hasAuthorship W4384197655A5008480409 @default.
• W4384197655 hasAuthorship W4384197655A5018713975 @default.
• W4384197655 hasAuthorship W4384197655A5045307915 @default.
• W4384197655 hasAuthorship W4384197655A5050374563 @default.
• W4384197655 hasAuthorship W4384197655A5072580346 @default.
• W4384197655 hasAuthorship W4384197655A5076983796 @default.
• W4384197655 hasBestOaLocation W43841976551 @default.
• W4384197655 hasConcept C108625454 @default.
• W4384197655 hasConcept C126322002 @default.
• W4384197655 hasConcept C137610392 @default.
• W4384197655 hasConcept C143998085 @default.
• W4384197655 hasConcept C153911025 @default.
• W4384197655 hasConcept C2776694085 @default.
• W4384197655 hasConcept C501593827 @default.
• W4384197655 hasConcept C55493867 @default.
• W4384197655 hasConcept C71924100 @default.
• W4384197655 hasConcept C86803240 @default.
• W4384197655 hasConceptScore W4384197655C108625454 @default.
• W4384197655 hasConceptScore W4384197655C126322002 @default.
• W4384197655 hasConceptScore W4384197655C137610392 @default.
• W4384197655 hasConceptScore W4384197655C143998085 @default.
• W4384197655 hasConceptScore W4384197655C153911025 @default.
• W4384197655 hasConceptScore W4384197655C2776694085 @default.
• W4384197655 hasConceptScore W4384197655C501593827 @default.
• W4384197655 hasConceptScore W4384197655C55493867 @default.
• W4384197655 hasConceptScore W4384197655C71924100 @default.
• W4384197655 hasConceptScore W4384197655C86803240 @default.
• W4384197655 hasLocation W43841976551 @default.
• W4384197655 hasLocation W43841976552 @default.
• W4384197655 hasLocation W43841976553 @default.
• W4384197655 hasOpenAccess W4384197655 @default.
• W4384197655 hasPrimaryLocation W43841976551 @default.
• W4384197655 hasRelatedWork W1980468385 @default.
• W4384197655 hasRelatedWork W1996181301 @default.
• W4384197655 hasRelatedWork W2017676762 @default.
• W4384197655 hasRelatedWork W2018922885 @default.
• W4384197655 hasRelatedWork W2048671695 @default.

• next